miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma

Can Shi1, Zhenyu Zhang2

  • 1Department of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.

Insights

MicroRNA-761 (miR-761) is downregulated in ovarian cancer and inhibits tumor cell proliferation and invasion. It targets MSI1, suggesting miR-761 as a potential therapeutic target for ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators of diverse biological processes.
  • The specific role of miR-761 in ovarian cancer pathogenesis remains largely uncharacterized.

Purpose of the Study:

  • To investigate the expression and function of miR-761 in ovarian cancer.
  • To elucidate the molecular mechanism underlying miR-761's role in ovarian cancer.

Main Methods:

  • Quantitative real-time PCR to assess miR-761 expression in ovarian cancer tissues and adjacent non-cancerous tissues.
  • In vitro assays to evaluate the effects of miR-761 overexpression on ovarian cancer cell proliferation and invasion.
  • Western blot analysis to determine the expression of MSI1 and its correlation with miR-761.

Main Results:

  • miR-761 expression was significantly reduced in ovarian cancer tissues compared to non-cancerous tissues.
  • Overexpression of miR-761 suppressed ovarian cancer cell proliferation and invasion.
  • miR-761 directly targeted MSI1, and their expression levels were inversely correlated in ovarian cancer tissues.

Conclusions:

  • miR-761 functions as a tumor suppressor in ovarian cancer.
  • The miR-761/MSI1 axis plays a critical role in regulating ovarian cancer progression.
  • miR-761 represents a potential therapeutic biomarker for ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K